Explore the vast range of titles available.

Pursuing Gender Equity in Primary CareGender-based pay disparities underscore the need to design a payment system that adequately compensates physicians for the thoughtful, relationship-based care that defines excellent primary care.

This study brings trans women to the forefront of global discourse on gender‐based economic inequalities. Such discussions, often lacking intersectionality and narrowly focused on cis women, have frequently overlooked the distinct economic obstacles trans women face in cisheteropatriarchal societies. Grounded in critical trans politics and intersectionality, this research explores the lives of five trans women in South Africa, examining the contextual norms, practices, and policies that shape their experiences of economic inclusion and exclusion. Findings reveal that economic marginality for trans women is upheld by social institutions prioritizing cisgender norms, reinforcing biology‐based gender binaries that render those existing outside these frameworks vulnerable, disposable, and disenfranchised. This structural economic bias is reflected in four key areas: (a) patriarchal family systems enforce conformity to cisgender expectations through abuse, financial neglect, and rejection, displacing trans women into precarious circumstances, including homelessness and survival sex work; (b) cisnormative workplace conventions demand legal gender alignment as a precondition for organizational access and employability, shutting out trans identities lacking state recognition of their gender; (c) institutionally entrenched anti‐trans stigma creates heightened scrutiny and discrimination during hiring processes; and (d) a gender‐segregated labor system undermines trans women’s ability to participate in both “male” and “female” jobs due to nonadherence to traditional, biologically defined gender roles. These cisgender‐privileging norms intersect with racism and colonial‐apartheid legacies, compounding economic difficulties for trans women. By mapping the economic conditions of historically invisibilized trans women, this study deepens the scope of economic transformation theories. It calls for a trans‐inclusive, intersectional model of economic justice, advocating for institutional cultures that embrace diverse gender expressions beyond static gender classifications.

The role of the National Health Service (NHS) and relevant national executive agencies in relation to testing capacity, availability of personal protective equipment (PPE), the cancellation and postponement of many aspects of routine care, and decisions around discharge from hospital to care homes should also be critically examined. [...]improve resource management across health and care at national, local, and treatment levels. [...]develop a sustainable, skilled, and fit for purpose health and care workforce to meet changing health and care needs. [...]improve integration between health care, social care, and public health and across different providers, including the third sector (ie, charity and voluntary organisations).

COVID-19 has affected vulnerable populations disproportionately across China and the world. Solid social and scientific evidence to tackle health inequity in the current COVID-19 pandemic is in urgent need.

Between 1991 and 2015, the cancer mortality rate declined dramatically in the United States, reflecting improvements in cancer prevention, screening, treatment, and survivorship care. However, cancer outcomes in the United States vary substantially between populations defined by race/ethnicity, socioeconomic status, health insurance coverage, and geographic area of residence. Many potentially preventable cancer deaths occur in individuals who did not receive effective cancer prevention, screening, treatment, or survivorship care. At the same time, cancer care spending is large and growing, straining national, state, health insurance plans, and family budgets. Indeed, one of the most pressing issues in American medicine is how to ensure that all populations, in every community, derive the benefit from scientific research that has already been completed. Addressing these questions from the perspective of health care delivery is necessary to accelerate the decline in cancer mortality that began in the early 1990s. This article, part of the Cancer Control Blueprint series, describes challenges with the provision of care across the cancer control continuum in the United States. It also identifies goals for a high‐performing health system that could reduce disparities and the burden of cancer by promoting the adoption of healthy lifestyles; access to a regular source of primary care; timely access to evidence‐based care; patient‐centeredness, including effective patient‐provider communication; enhanced coordination and communication between providers, including primary care and specialty care providers; and affordability for patients, payers, and society.

Increasing attention is being paid to the inequity that pervades global health research. One behind-the-scenes component of the research enterprise that hasn’t been addressed is the indirect cost rate.

Background The inequitable allocation of health resources is a worldwide problem, and it is also one of the obstacles facing for health services utilization in China. A new round of health care reform which contains the important aspect of improving the equity in health resource allocation was released by Chinese government in 2009. The aim of this study is to understand the changes of equity in health resource allocation from 2009 to 2013, and make a further inquiry of the main factors which influence the equity conditions in China. Methods Data resources are the China Health Statistics Yearbook (2014) and the China Statistical Yearbook (2014). Four indicators were chosen to measure the trends in equity of health resource allocation. Data were disaggregated by three geographical regions: west, central, and east. Theil index was used to calculate the degree of unfairness. Results The total amount of health care resources in China had been increasing in recent years. However, the per 10, 000 km 2 number of health resources showed a huge gap in different regions, and per 10, 000 capita health resources ownership showed a relatively small disparities at the same time. The index of health resources showed an overall downward trend, in which health financial investment the most unfair from 2009 to 2012 and the number of health institutions the most unfair in 2013. The equity of health resources allocation in eastern regions was the worst except for the aspect of health technical personnel allocation. The regional contribution rates were lower than that of the inter-regional contribution rates which were all beyond 60 %. Conclusion The equity of health resource allocation improved gradually from 2009 to 2013. However, the internal differences within the eastern region still have a huge impact on the overall equity in health resource allocation. The tough issues of inequitable in health resource allocation should be resolved by comprehensive measures from a multidisciplinary perspective.

The social cost of methane (SC-CH 4 ) measures the economic loss of welfare caused by emitting one tonne of methane into the atmosphere. This valuation may in turn be used in cost–benefit analyses or to inform climate policies 1 – 3 . However, current SC-CH 4 estimates have not included key scientific findings and observational constraints. Here we estimate the SC-CH 4 by incorporating the recent upward revision of 25 per cent to calculations of the radiative forcing of methane 4 , combined with calibrated reduced-form global climate models and an ensemble of integrated assessment models (IAMs). Our multi-model mean estimate for the SC-CH 4 is US$933 per tonne of CH 4 (5–95 per cent range, US$471–1,570 per tonne of CH 4 ) under a high-emissions scenario (Representative Concentration Pathway (RCP) 8.5), a 22 per cent decrease compared to estimates based on the climate uncertainty framework used by the US federal government 5 . Our ninety-fifth percentile estimate is 51 per cent lower than the corresponding figure from the US framework. Under a low-emissions scenario (RCP 2.6), our multi-model mean decreases to US$710 per tonne of CH 4 . Tightened equilibrium climate sensitivity estimates paired with the effect of previously neglected relationships between uncertain parameters of the climate model lower these estimates. We also show that our SC-CH 4 estimates are sensitive to model combinations; for example, within one IAM, different methane cycle sub-models can induce variations of approximately 20 per cent in the estimated SC-CH 4 . But switching IAMs can more than double the estimated SC-CH 4 . Extending our results to account for societal concerns about equity produces SC-CH 4 estimates that differ by more than an order of magnitude between low- and high-income regions. Our central equity-weighted estimate for the USA increases to US$8,290 per tonne of CH 4 whereas our estimate for sub-Saharan Africa decreases to US$134 per tonne of CH 4 . Accounting for equity influences the social cost of methane more than climate model uncertainty does and produces results that differ by over an order of magnitude between low- and high-income regions.

There is increasing evidence for the effectiveness of population-based policies to reduce the burden of type 2 diabetes. Yet, there are concerns about the equity effects of some policies, whereby socioeconomically disadvantaged populations are not reached or are adversely affected. There is a lack of knowledge on the effectiveness and equity of policies that are both population based (i.e. targeting both at-risk and low-risk populations) and low agency (i.e. not requiring personal resources to benefit from the policy). In this narrative review, we selected 16 policies that were both population based and low agency and reviewed the evidence on their effectiveness and equity. Substantial evidence suggests that fruit and vegetable subsidies, unhealthy food taxes, mass media campaigns, and school nutrition and physical activity education are effective in promoting healthier lifestyle behaviours. Less evidence was available for mandatory food reformulation, reduced portion sizes, marketing restrictions and restriction of availability and promotion of unhealthy products, although the available evidence suggested that these policies were effective in reducing unhealthy food choices. Effects could rarely be quantified across different studies due to substantial heterogeneity. There is an overall lack of evidence on equity effects of population-based policies, although available studies mostly concluded that the policies had favourable equity effects, with the exception of food-labelling policies. Each of the policies is likely to have a relatively modest effect on population-level diabetes risks, which emphasises the importance of combining different policy measures. Future research should consider the type of evidence needed to demonstrate the real-world effectiveness and equity of population-based diabetes prevention policies. Graphical Abstract